Zkusit zdarma
Cabaletta Bio, Inc.

Cabaletta Bio, Inc.

CABA
Cena:
$ 3.65
-0.04 (-1.08%)
Valuace
70
Růst
8
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?

Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?

10:40 20-05-2026

Here is how Cabaletta Bio, Inc. (CABA) and Curaleaf Holdings, Inc. (CURLF) have performed compared t...

Cabaletta Bio (CABA) Upgraded to Buy: Here's Why

Cabaletta Bio (CABA) Upgraded to Buy: Here's Why

13:01 18-05-2026

Cabaletta Bio (CABA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about t...

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

7:05 14-05-2026

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose ...

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

7:00 14-05-2026

A single infusion of the lowest dose of rese-cel administered without preconditioning, after discont...

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

6:35 04-05-2026

PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Compan...

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

8:00 28-04-2026

Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many th...

Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel

Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel

8:00 28-04-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac...

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

17:00 27-04-2026

PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage cl...

First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

16:30 14-04-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac...

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

7:30 23-03-2026

Rese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational ...

Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference

Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference

1:02 09-03-2026

Cabaletta Bio (NASDAQ: CABA) used a fireside chat at TD Cowen's 46th Annual Health Care Conference t...

Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know

Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know

13:01 06-03-2026

Cabaletta Bio (CABA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about t...

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

8:00 05-02-2026

PHILADELPHIA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage cli...

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?

13:00 30-01-2026

Does Cabaletta Bio, Inc. (CABA) have what it takes to be a top stock pick for momentum investors? Le...

Cabaletta Bio: Do You Buy With The Insiders?

Cabaletta Bio: Do You Buy With The Insiders?

11:01 27-01-2026

Cabaletta Bio continues to advance its engineered cell therapy pipeline targeting autoimmune disease...

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?

10:41 27-01-2026

Here is how Cabaletta Bio, Inc. (CABA) and Celcuity, Inc. (CELC) have performed compared to their se...

Cabaletta Bio Announces 2026 Strategic Priorities

Cabaletta Bio Announces 2026 Strategic Priorities

8:00 12-01-2026

Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BL...

IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms

IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms

7:30 12-01-2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac...

Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

17:23 03-12-2025

Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript...

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

7:30 10-11-2025

Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-f...

close

CABALETTA BIO TO PARTICIPATE IN THE GUGGENHEIM EMERGING OUTLOOK: BIOTECH SUMMIT 2026

05-02-2026
PHILADELPHIA, FEB. 05, 2026 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A LATE-STAGE CLI...
Více zde

CABALETTA BIO ANNOUNCES 2026 STRATEGIC PRIORITIES

12-01-2026
REGISTRATIONAL MYOSITIS TRIAL ACTIVELY ENROLLING WITH PLANNED 17-PATIENT COHORT AND 2027 RESE-CEL BL...
Více zde

IND AMENDMENT CLEARANCE OBTAINED FOR CLINICAL MANUFACTURING OF RESE-CEL FROM CABALETTA BIO USING CELLARES' AUTOMATED PLATFORMS

12-01-2026
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--CELLARES, THE FIRST INTEGRATED DEVELOPMENT AND MANUFAC...
Více zde

CABALETTA BIO REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

10-11-2025
RESE-CEL DATA PRESENTED AT MULTIPLE MEDICAL MEETINGS DEMONSTRATED POTENTIALLY TRANSFORMATIVE, DRUG-F...
Více zde

CABALETTA BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBER

04-11-2025
PHILADELPHIA, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO PRESENTS POSITIVE CLINICAL DATA AND DEVELOPMENT UPDATES FOR RESE-CEL AT ACR CONVERGENCE 2025

27-10-2025
– ALL MYOSITIS PATIENTS IN THE PHASE 1/2 DM/ASYS COHORT WITH SUFFICIENT FOLLOW-UP WHO MET KEY REGI...
Více zde

CABALETTA BIO ANNOUNCES APPOINTMENT OF STEVE GAVEL AS CHIEF COMMERCIAL OFFICER AND AWARD OF INDUCEMENT GRANT

14-10-2025
– GAVEL BRINGS HIGHLY RELEVANT CAR T EXPERIENCE FROM LEGEND BIOTECH WHERE HE LED THE LAUNCH AND CO...
Více zde

CABALETTA BIO PRESENTS FIRST RESE-CEL DATA WITH NO PRECONDITIONING DEMONSTRATING BIOLOGIC ACTIVITY AND EARLY CLINICAL RESPONSES AT THE 2025 ESGCT ANNUAL CONGRESS

09-10-2025
– COMPLETE B CELL DEPLETION, RAPID REDUCTION IN AUTOANTIBODIES AND NEAR-COMPLETE RESOLUTION OF CLI...
Více zde

CABALETTA BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER

27-08-2025
PHILADELPHIA, AUG. 27, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

07-08-2025
– REGISTRATIONAL COHORT ENROLLMENT IN RESET-MYOSITIS™ TRIAL ON TRACK TO START IN 2H25 WITH ANTIC...
Více zde

CABALETTA BIO ANNOUNCES PRICING OF PUBLIC OFFERING OF SECURITIES

11-06-2025
PHILADELPHIA, JUNE 11, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (“CABALETTA” OR THE “COMPA...
Více zde

CABALETTA BIO ANNOUNCES PROPOSED PUBLIC OFFERING OF SECURITIES

11-06-2025
PHILADELPHIA, JUNE 11, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (“CABALETTA” OR THE “COMPA...
Více zde

CABALETTA BIO ANNOUNCES NEW RESE-CEL SAFETY AND EFFICACY DATA IN PATIENTS WITH MYOSITIS, LUPUS AND SCLERODERMA TO BE PRESENTED AT THE EULAR 2025 CONGRESS

11-06-2025
– 7 OF 8 MYOSITIS PATIENTS ACHIEVED CLINICALLY MEANINGFUL TIS RESPONSES AFTER DISCONTINUATION OF A...
Více zde

CABALETTA BIO TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2025
PHILADELPHIA, MAY 29, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE ...
Více zde

CABALETTA BIO ANNOUNCES 2027 RESE-CEL BLA SUBMISSION ANTICIPATED IN MYOSITIS FOLLOWING RECENT FDA ALIGNMENT ON REGISTRATIONAL COHORTS

15-05-2025
– TWO SUBTYPE SPECIFIC COHORTS WITH ~15 PATIENTS EACH ADDED TO THE ONGOING RESET-MYOSITIS™ TRIA...
Více zde

CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

31-03-2025
– FDA MEETING TO ALIGN ON MYOSITIS REGISTRATIONAL TRIAL DESIGNS FOR RESE-CEL IN 1H25 ON TRACK – ...
Více zde

CELLARES AND CABALETTA BIO SUCCESSFULLY COMPLETE MANUFACTURING TECHNOLOGY ADOPTION PROGRAM FOR RESE-CEL USING THE CELL SHUTTLE™ PLATFORM

19-03-2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--CELLARES, THE FIRST INTEGRATED DEVELOPMENT AND MANUFAC...
Více zde

CABALETTA BIO TO PARTICIPATE IN THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE

26-02-2025
PHILADELPHIA, FEB. 26, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

UPDATE - CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS

18-02-2025
– CLINICAL EFFICACY CONTINUED TO DEEPEN OVER TIME WITH THREE SLE PATIENTS IN DORIS REMISSION, THE ...
Více zde

CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA DEMONSTRATING DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS

18-02-2025
– CLINICAL EFFICACY CONTINUED TO DEEPEN OVER TIME WITH THREE SLE PATIENTS IN DORIS REMISSION, THE ...
Více zde

CABALETTA BIO ANNOUNCES PRESENTATIONS FEATURING UPDATED CLINICAL DATA ON RESE-CEL AT UPCOMING SCIENTIFIC MEETINGS IN FEBRUARY

11-02-2025
PHILADELPHIA, FEB. 11, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO TO PARTICIPATE IN GUGGENHEIM'S SMID CAP BIOTECH CONFERENCE

29-01-2025
PHILADELPHIA, JAN. 29, 2025 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO TO PRESENT NEW AND UPDATED CLINICAL DATA ON CABA-201 IN ORAL AND POSTER PRESENTATIONS AT ACR CONVERGENCE 2024

25-09-2024
PHILADELPHIA, SEPT. 25, 2024 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAG...
Více zde

CABALETTA BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER

28-08-2024
PHILADELPHIA, AUG. 28, 2024 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

08-08-2024
– NINE PATIENTS ENROLLED AS OF AUGUST 5, 2024 ACROSS THE RESET™ CLINICAL DEVELOPMENT PROGRAM, IN...
Více zde

CABALETTA BIO TO PARTICIPATE IN THE STIFEL 2024 VIRTUAL CELL THERAPY FORUM

02-07-2024
PHILADELPHIA, JULY 02, 2024 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE...
Více zde

CABALETTA BIO REPORTS POSITIVE INITIAL CLINICAL DATA FROM PHASE 1/2 RESET-MYOSITIS™ AND RESET-SLE™ TRIALS OF CABA-201

14-06-2024
– NO CRS, ICANS, INFECTIONS OR SERIOUS ADVERSE EVENTS OBSERVED IN EITHER OF THE FIRST TWO PATIENTS...
Více zde

CABALETTA BIO REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

15-05-2024
– NO CRS OR ICANS OF ANY GRADE OBSERVED DURING THE 28-DAY DLT OBSERVATION WINDOW FOR EITHER OF THE...
Více zde

CABALETTA BIO TO PARTICIPATE IN THE H.C. WAINWRIGHT 2ND ANNUAL BIOCONNECT INVESTOR CONFERENCE AT NASDAQ

13-05-2024
PHILADELPHIA, MAY 13, 2024 (GLOBE NEWSWIRE) -- CABALETTA BIO, INC. (NASDAQ: CABA), A CLINICAL-STAGE ...
Více zde

CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

21-03-2024
– FIRST PATIENT DOSED WITH CABA-201 IN THE RESET™ (RESTORING SELF-TOLERANCE) CLINICAL TRIAL PROG...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-10-29 00:00:008-KStáhnout
2025-10-27 00:00:008-KStáhnout
2025-10-09 01:00:008-KStáhnout
2025-10-09 00:00:008-KStáhnout
2025-09-03 01:00:008-KStáhnout
2025-09-03 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-06-11 01:00:008-KStáhnout
2025-06-11 00:00:008-KStáhnout
2025-06-10 01:00:008-KStáhnout
2025-06-10 00:00:008-KStáhnout
2025-05-19 01:00:008-KStáhnout
2025-05-19 00:00:008-KStáhnout
2025-05-15 01:00:008-KStáhnout
2025-05-15 01:00:0010-QStáhnout
2025-05-15 00:00:008-KStáhnout
2025-05-15 00:00:0010-QStáhnout
2025-03-31 01:00:008-KStáhnout
2025-03-31 01:00:0010-KStáhnout
2025-03-31 00:00:008-KStáhnout
2025-03-31 00:00:0010-KStáhnout
2025-02-18 00:00:008-KStáhnout
2025-02-17 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-18 00:00:008-KStáhnout
2024-11-17 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-10-07 01:00:008-KStáhnout
2024-10-07 00:00:008-KStáhnout
2024-09-30 01:00:008-KStáhnout
2024-09-30 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-06-04 01:00:008-KStáhnout
2024-06-04 00:00:008-KStáhnout
2024-05-15 01:00:008-KStáhnout
2024-05-15 01:00:0010-QStáhnout
2024-05-15 00:00:008-KStáhnout
2024-05-15 00:00:0010-QStáhnout
2024-03-21 00:00:008-KStáhnout
2024-03-21 00:00:0010-KStáhnout
2024-03-20 23:00:008-KStáhnout
2024-03-20 23:00:0010-KStáhnout
2024-03-20 00:00:008-KStáhnout
2024-03-19 23:00:008-KStáhnout
2024-02-01 00:00:008-KStáhnout
2024-01-31 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-10-02 01:00:008-KStáhnout
2023-10-02 00:00:008-KStáhnout
2023-09-05 01:00:008-KStáhnout
2023-09-05 00:00:008-KStáhnout
2023-08-22 01:00:008-KStáhnout
2023-08-22 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-07-24 01:00:008-KStáhnout
2023-07-24 00:00:008-KStáhnout
2023-06-01 01:00:008-KStáhnout
2023-06-01 00:00:008-KStáhnout
2023-05-22 01:00:008-KStáhnout
2023-05-22 00:00:008-KStáhnout
2023-05-18 01:00:008-KStáhnout
2023-05-18 00:00:008-KStáhnout
2023-05-16 01:00:008-KStáhnout
2023-05-16 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-05-02 01:00:008-KStáhnout
2023-05-02 00:00:008-KStáhnout
2023-05-01 01:00:008-KStáhnout
2023-05-01 00:00:008-KStáhnout
2023-03-31 01:00:008-KStáhnout
2023-03-31 00:00:008-KStáhnout
2023-03-16 00:00:008-KStáhnout
2023-03-16 00:00:0010-KStáhnout
2023-03-15 23:00:008-KStáhnout
2023-03-15 23:00:0010-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-12-08 00:00:008-KStáhnout
2022-12-07 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-10-11 01:00:008-KStáhnout
2022-10-11 00:00:008-KStáhnout
2022-08-29 01:00:008-KStáhnout
2022-08-29 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-02 01:00:008-KStáhnout
2022-06-02 00:00:008-KStáhnout
2022-05-18 01:00:008-KStáhnout
2022-05-18 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-05-02 01:00:008-KStáhnout
2022-05-02 00:00:008-KStáhnout
2022-03-17 00:00:008-KStáhnout
2022-03-17 00:00:0010-KStáhnout
2022-03-16 23:00:008-KStáhnout
2022-03-16 23:00:0010-KStáhnout
2022-03-03 00:00:008-KStáhnout
2022-03-02 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-14 00:00:008-KStáhnout
2021-12-13 23:00:008-KStáhnout
2021-11-01 00:00:008-KStáhnout
2021-11-01 00:00:0010-QStáhnout
2021-10-31 23:00:008-KStáhnout
2021-10-31 23:00:0010-QStáhnout
2021-08-18 01:00:008-KStáhnout
2021-08-18 00:00:008-KStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-06-28 01:00:008-KStáhnout
2021-06-28 00:00:008-KStáhnout
2021-06-03 01:00:008-KStáhnout
2021-06-03 00:00:008-KStáhnout
2021-05-03 01:00:008-KStáhnout
2021-05-03 01:00:0010-QStáhnout
2021-05-03 00:00:008-KStáhnout
2021-05-03 00:00:0010-QStáhnout
2021-04-06 01:00:008-KStáhnout
2021-04-06 00:00:008-KStáhnout
2021-03-16 00:00:008-KStáhnout
2021-03-16 00:00:0010-KStáhnout
2021-03-15 23:00:008-KStáhnout
2021-03-15 23:00:0010-KStáhnout
2020-12-08 00:00:008-KStáhnout
2020-12-07 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-03 01:00:008-KStáhnout
2020-06-03 00:00:008-KStáhnout
2020-05-28 01:00:008-KStáhnout
2020-05-28 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 01:00:0010-QStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-12 00:00:0010-QStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-03-30 01:00:008-KStáhnout
2020-03-30 01:00:0010-KStáhnout
2020-03-30 00:00:008-KStáhnout
2020-03-30 00:00:0010-KStáhnout
2020-02-20 00:00:008-KStáhnout
2020-02-19 23:00:008-KStáhnout
2020-01-29 00:00:008-KStáhnout
2020-01-28 23:00:008-KStáhnout
2020-01-10 00:00:008-KStáhnout
2020-01-09 23:00:008-KStáhnout
2019-12-05 00:00:0010-QStáhnout
2019-12-04 23:00:0010-QStáhnout
2019-10-30 00:00:008-KStáhnout
2019-10-29 23:00:008-KStáhnout
preloader